Despite the exploration of the potential therapeutic utility of these peripheral signals, including the use of incretins, a group of metabolic hormones that lower blood sugar levels by increasing insulin secretion from the pancreas, inhibiting the secretion of glucagon, and reducing nutrient absorption, no successful treatments for obesity have been found [54,55]. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.